IBD Anniversary OfferIBD Anniversary Offer


Nasdaq Up On Amazon, Alibaba And This Biotech

X

Stocks were narrowly mixed in early Wednesday trading as earnings continued to drive stocks and Brexit started overseas. The Nasdaq composite led thanks to gains from biotechs and internet retailers.

The Nasdaq composite held a 0.2% gain, the S&P 500 was about flat and the Dow Jones industrial average dipped 0.2%. The small cap Russell 2000 was down 0.2%. Volume was tracking slightly higher on the NYSE and Nasdaq in the stock market today vs. the same time Tuesday.

Biotechs and retailers led, while steel and utilities lagged. Wal-Mart (WMT) and Merck (MRK), each up about 1%, were the top gainers on the Dow. But Home Depot (HD) and Travelers Cos. (TRV) were each down more than 0.5%.

Internet retailers showed strength as Amazon (AMZN) and Alibaba Group (BABA) rose 1% each. Both stocks are in buy range from their respective entries.

 Vertex Pharmaceuticals (VRTX) soared more than 23% to 110.35 and a 14-month high, gapping up past a 95.10 buy point of a bottoming base in massive trade.

The biotech late Tuesday said clinical trials for a drug combo of tezacaftor and Kalydeco to treat cystic fibrosis showed positive results. It plans to seek marketing approval from the FDA and the European Medicines Agency.

Dave & Buster's (PLAY) fell 4% in heavy turnover, dropping the stock back to 60.02 and into buy range from a 58.35 flat-base entry. After the close Tuesday, the restaurant and arcade chain reported Q4 results that topped views on the top and bottom lines. But the midpoint of its full-year revenue outlook was slightly below the Street's consensus estimates.

 Ollie's Bargain Outlet (OLLI) popped nearly 4% in fast turnover. Shares remain in buy range from a 33.55 flat-base entry.

The deep discount retailer late Tuesday reported better-than-expected Q4 per-share earnings and sales, extending double-digit gains on both for a 13th straight quarter.

Its full-year EPS outlook and the midpoint of its revenue guidance range were higher than consensus.

 Lululemon Athletica (LULU) gained 1% ahead of its Q4 earnings report after the close. Analysts expect the yoga wear maker to earn $1.01 a share on $783.6 million in sales. That would mark respective year-over-year increases of 19% and 11%.

RELATED:

Dave & Buster's Guides Light After Q4 Beats; Ollie's Tops, Guides High

Dow's JPMorgan Retakes Key Support; Tesla In Focus: Investing Action Plan

Vertex Stock Rockets On Strong Cystic Fibrosis Data